Skip to content

Solta Fraxel Dual (re:store Dual)

Save device

Non-Ablative Fractional · 1550nm + 1927nm thulium fractional

Classification & configurations

Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)

Current

At a glance

New price
$90k–$120kSource not documented
Used asking price
$20k–$45kSource not documented
FDA status
Supplies & recurring costs
See supply and replacement costs below.
View supply details
Sources and verified data on file

Data on file

Recurring consumables
Not verified
FDA
FDA ClearedK130193, K062303
Used asking prices
Not verified
  • This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
  • Bottle prices and estimates may still appear under Treatment & running costs.
  • The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.

Figures are reference points, not current offers. Used asking prices are not completed-sale values.

Read FDA-cleared indicationsExact wording from 2 FDA records

K130193 (Solta Medical, Inc., 2013)

1550 nm: The Fraxel 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. It is also indicated for treatment of dyschromia and cutaneous lesions, such as, but not limited to lentigos (age spots), solar lentigos (sun spots), actinic keratosis, and melasma, and for treatment of periorbital wrinkles, acne scars and surgical scars. 1927 nm: The Fraxel 1927 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles).

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K062303 (Reliant Technologies, Inc., 2007)

STATEMENT The Fraxel II SR Laser System is intended for use in: Dermatological procedures requiring the coagulation of soft tissue; Treatment of periorbital wrinkles; Treatment of acne scars and surgical scars; Photocoagulation of pigmented lesions, such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and dyschromia; Skin resurfacing procedures.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Page updated: August 6, 2026 · How we verify

New and used price references
New$90k–$120k
Source not documented
Used$20k–$45k
Source not documented

Axis runs $0–$120k. Reference figures, not current offers. Used asking prices are not completed-sale values.

Consumable cost per treatment

Not verified

We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.

Price sourcesSources, dates and configurations
New: $90k–$120k·Researched estimate — no dated source on file yet; not a quote.
Used asking range: $20k–$45k·Researched estimate — no dated source on file yet; not a quote.
Key factsCompany, specifications and verification dates
Key facts
ManufacturerSolta
CompanyOwner: Bausch Health Companies Inc. (NYSE/TSX: BHC) (subsidiary, since 2014) · Distribution: direct
Parent companySolta Medical (Bausch Health)
Brand ownerSolta
Built by (OEM)Solta Medical Inc.
CategoryNon-Ablative Fractional
Technology1550nm + 1927nm thulium fractional
FDA statusFDA Cleared
510(k) citationK130193, K062303
New price range$90k–$120k
Used asking range$20k–$45k
ConsumablesNot published
Launch year2009
PricingNot published
Manufacturer-source documents checkedNot published

Overview

Still-current melasma/photodamage standard

How it worksTechnology and manufacturing

How the technology works

Non-ablative fractional laser with two wavelengths: 1550nm erbium fiber creating microscopic coagulated columns deep in the dermis (collagen remodeling, acne scars, wrinkles, texture) and 1927nm thulium working superficially — excellent for sun spots, dyschromia, and actinic keratoses.

Nothing is vaporized; expect redness and bronzing/flaking for 3-7 days rather than open wounds. Protocols layer passes to a target density; results build over a series.

Patented technology

Fraxel is the foundational fractional-photothermolysis brand — the concept the whole category is named after; the Dual's differentiator is both wavelengths in one handpiece with Intelligent Optical Tracking metering microbeam delivery as the operator rolls the tip.

Origin

US-designed, historically built in Hayward, California (Solta/Bausch) — verify current site.

FDA & regulatory detailClearance timeline, authorization route and citation notes
Authorized via 510(k)

FDA-cleared indications (verbatim)

K130193 (Solta Medical, Inc., 2013)

1550 nm: The Fraxel 1550 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, as well as for skin resurfacing procedures. It is also indicated for treatment of dyschromia and cutaneous lesions, such as, but not limited to lentigos (age spots), solar lentigos (sun spots), actinic keratosis, and melasma, and for treatment of periorbital wrinkles, acne scars and surgical scars. 1927 nm: The Fraxel 1927 nm laser is indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles).

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

K062303 (Reliant Technologies, Inc., 2007)

STATEMENT The Fraxel II SR Laser System is intended for use in: Dermatological procedures requiring the coagulation of soft tissue; Treatment of periorbital wrinkles; Treatment of acne scars and surgical scars; Photocoagulation of pigmented lesions, such as, but not limited to lentigos (age spots), solar lentigos (sun spots) and dyschromia; Skin resurfacing procedures.

Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.

Marketed for

Non-Ablative Fractional — 1550nm + 1927nm thulium fractional

Marketing claims are the manufacturer's own and are not the same as a cleared indication.

510(k) numbers

K130193, K062303

Parent company: Solta Medical (Bausch Health)

Legal manufacturer: Solta Medical Inc. (United States)

Applicant on the FDA record

Solta Medical, Inc.The applicant named on the FDA record can differ from the brand shown on the device.

Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.

Treatment & running costs

Treatments

Sessions & timing

No treatment schedule documented yet.

What practices charge

No sourced treatment price on file.

Supplies & recurring costs

Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Annual service & support

No annual service cost documented yet.

Payback calculatorModel your own volume, labor and service costs

Estimate your payback

Pre-filled from our published Solta Fraxel Dual (re:store Dual) data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.

Start from

No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.

Pre-filled from the midpoint of the published new-price range

20 is an illustrative default — change it to your volume.

No sourced per-session price on file — enter what you charge.

Required — enter your cost; missing data does not mean $0.

Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.

Annual service contract ÷ 12, if you carry one.

Your estimate

Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.

This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.

ComplianceScreening and contraindications on the manufacturer's record

Contraindications & screening

Pregnancy, recent isotretinoin, active infection/herpes history, keloids, and melasma expectations management (it can help or flare it); non-ablative is more forgiving on IV-VI but still demands conservative densities.

Warranty & serviceWhat to confirm in writing before you buy

Before buying new or used, confirm in writing:

  • Current warranty coverage
  • Included training
  • Service terms

Chains using this device

A chain listing does not establish availability at every location.

No confirmed chain deployments recorded yet.

Owner & operator reviews

Write a review

No owner or operator reviews yet. Be the first →

Current alternatives

Current catalog models to research. Confirm availability and configuration with the supplier.

Solta Medical Fraxel FTX

Non-Ablative Fractional

Lutronic LaseMD Ultra

Non-Ablative Fractional · $60k–$90k

Research comparisons

Includes current and older models.

History1 tracked change

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Cite this data: The Aesthetic Index, "Solta Fraxel Dual (re:store Dual) — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).

Get the full State of Aesthetic Devices 2026 report

A catalog of US-marketed aesthetic and wellness devices — preview it free.

Get the report

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.